Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesHistone deacetylase signaling in cardioprotectionHopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferationThe many roles of histone deacetylases in development and physiology: implications for disease and therapyHDAC and HDAC Inhibitor: From Cancer to Cardiovascular DiseasesA neonatal blueprint for cardiac regenerationTrpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterationsTargeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular diseaseThe cardiac acetyl-lysine proteomeInpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsivenessHighly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotencyEpicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis.Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice.Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive ratsAcetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytesEpigenetic mechanisms in heart failure pathogenesisLeft ventricular hypertrophy is prevalent in Sprague-Dawley rats.HDAC3 controls gap 2/mitosis progression in adult neural stem/progenitor cells by regulating CDK1 levels.The Huntington's disease-related cardiomyopathy prevents a hypertrophic response in the R6/2 mouse model.Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.Epigenetic regulation of cardiac myocyte differentiation.Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.How the proteome packages the genome for cardiovascular development.Chromatin remodeling in cardiovascular development and physiology.Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells.Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.Histone deacetylase 3 regulates smooth muscle differentiation in neural crest cells and development of the cardiac outflow tractTrichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models.Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.Histone Deacetylase 3 Coordinates Deacetylase-independent Epigenetic Silencing of Transforming Growth Factor-β1 (TGF-β1) to Orchestrate Second Heart Field DevelopmentMetabolic stress in the myocardium: adaptations of gene expression.HDAC-dependent ventricular remodeling.Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.Targeting histone deacetylases for heart failure.Multiple roles of class I HDACs in proliferation, differentiation, and development.Epigenetics of the failing heart.Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression.Homeodomain only protein x is down-regulated in human heart failure.A new (heat) shocking player in cardiac hypertrophy.
P2860
Q21284678-B9DC1F7E-EFC5-4809-A17A-4AF6F853A766Q24568237-61FE6AFC-7809-4D67-BDF4-52F266D6DD1AQ24597593-D407E86F-89B9-4B6B-95B5-65411C2AC689Q24628821-04FCC4CC-AD14-48B6-B8B2-4D2703676B6AQ26766640-4DC3B480-382A-4DD6-899A-26B8EED43227Q26827943-9BC738A6-08FF-4F51-AD8E-ED983A5D7299Q27320040-1932717A-4004-419F-8041-DB1A21BBAE62Q28085588-A7AEFEE8-7DC6-431C-B7A1-06C75AE2656EQ28534479-9F319264-9F0F-46BC-B7F9-5D75F33FE577Q28590549-2509C764-78C0-46BC-9903-210EB850EC85Q29616797-9198ECD3-41F9-47CB-8F85-DDC1C054B04AQ33564987-F07091AE-285D-4750-9DFA-996BAAAAAFC2Q33581898-4BD6189F-5F9A-4AE0-B0B0-E5F507631070Q33772867-8E8F59D7-21A0-4B27-AD1F-AF5F91A75579Q34173928-2D03F697-7FF4-421C-ADD2-972D5BA8207BQ34212728-8049A1C9-7B0C-4B57-B248-327EC293FFF9Q34217404-D40654DE-E971-477F-B055-0E37CF00A4A8Q34218076-E6EA7F9A-5042-47CC-83D0-694B2754C957Q34277801-0180EF2C-7BAF-45EC-9D1C-9BA708B03154Q34383040-A7F5340D-F1AC-4D96-AB73-A2DA11551046Q34449181-F93E9534-48C3-4D64-9A77-9827D0D48D20Q34685319-10D87E32-C9D6-4323-97C9-2BD9F1B75481Q34730243-CD5A072D-DC98-49F7-B62C-6FF41C48E627Q34814306-945A7A06-2435-4F25-A72B-8F9921009A80Q35021108-A245C87D-805D-4C20-BF4C-B1868868E507Q35045900-83869F7E-F70A-4FD5-B994-51433C4BBB81Q35517710-09DCCE33-ED7D-41D3-9FC4-FC4BA87F75EEQ35576426-CB141307-DE0D-4886-9846-D55D7F28B39EQ35813871-1A876767-4CA8-4C9D-93A5-0B0E2FF8600BQ35813885-2DAD8DD8-4946-4CE2-909B-2761CE4C7CE5Q36283869-08567E63-3D0D-466C-86CB-289597BE0D82Q36328486-98643BC5-90FC-4894-B7FA-6D029AC5DD15Q36945016-D592CF34-246F-43E1-A854-5A069547F178Q37353815-2966B583-24E8-4D02-9D42-FD10603A295EQ37494673-C700DE41-5DD2-410B-BEBD-33B831276B51Q37979639-36902BDA-914D-4E1C-94BE-219300E5D53FQ38408408-7FEE64F4-FF63-4B2C-950E-7C8E3268A783Q40644814-88247B22-7E61-410B-BD4C-74C908CAD9E9Q41860424-EF797A50-4FCF-46CD-B593-5F05CBB1FAB6Q42733762-B618D919-658F-4F57-A17B-7CB6EB970BDE
P2860
Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Transgenic overexpression of H ...... t does not induce hypertrophy.
@en
type
label
Transgenic overexpression of H ...... t does not induce hypertrophy.
@en
prefLabel
Transgenic overexpression of H ...... t does not induce hypertrophy.
@en
P2093
P2860
P356
P1476
Transgenic overexpression of H ...... t does not induce hypertrophy.
@en
P2093
Chinmay M Trivedi
Jonathan A Epstein
Min Min Lu
Qiaohong Wang
P2860
P304
26484-26489
P356
10.1074/JBC.M803686200
P407
P577
2008-07-14T00:00:00Z